08:52 AM EDT, 10/09/2024 (MT Newswires) -- Health care stocks were mixed pre-bell Wednesday as the Health Care Select Sector SPDR Fund (XLV) was up 0.1% and the iShares Biotechnology ETF (IBB) was 0.5% lower recently.

Clearside Biomedical ( CLSD ) shares advanced by over 20% after the company said topline data from its phase 2b clinical trial of CLS-AX for the treatment of neovascular age-related macular degeneration achieved both primary and secondary outcomes.